Fresenius Group

The so-called CAR-T cell therapies are among the most innovative therapy options for malignant blood cancers, for example. They require the patient’s living cells, which are then prepared in a special way using an intricate process. The entire production process for these cell-based therapeutics is extremely complex and logistically challenging, making therapeutic applications expensive and limiting their accessibility. Fresenius Kabi is developing and producing two new devices that are essential to the CAR-T cell therapy process. Read more in our story about how the cell processing systems Lovo and Cue are revolutionizing the treatment of cancer patients by making the therapy production more efficient and accessible:??? https://lnkd.in/eCgJWChF #Cancer #CARTCellTherapy #CommittedToLife

Artificial Intelligence (AI) driving patient focus: With the Scribe project, our Quirónsalud clinics in Spain are bringing healthcare innovation to people. Doctors can fully concentrate on interacting with their patients, while administrative processes are automated. How does it work? Scribe creates Al-powered transcripts of the doctor-patient conversations, enabling the automated creation of high-quality patient reports and the direct integration of all relevant information into the digital patient record. Of course, the doctor and the patient jointly do a final check of the report. This is another step towards the meaningful use of technology, keeping healthcare to be human to human. #Healthcare #TeamFresenius #FutureFresenius #CommittedToLife

Dr. Eduard Fresenius laid the foundation for our global healthcare company by establishing a pharmaceutical enterprise in the back of his pharmacy. His entrepreneurial spirit still drives us today: For more than 100 years now, we have continued to evolve to help save and improve people's lives with affordable, accessible, and innovative healthcare products and the highest quality in clinical care. Today, on what would have been his 150th birthday, we remember his legacy that has led Fresenius to become a global leader in healthcare. #FutureFresenius #CommittedToLife

A recap of the opening ceremony for the new Helios Dr. Horst Schmidt Kliniken Wiesbaden! Take a look at the event highlights and experience impressions of one of the most modern hospitals in Germany. The recently completed construction of this maximum care provider marks a major milestone for patient-centered care and represents Fresenius' largest hospital investment project to date.

Today we are celebrating the newly opened Helios Dr. Horst Schmidt Kliniken Wiesbaden - one of the most modern hospitals in Germany and a milestone in patient-oriented healthcare at Fresenius! ?? The " hospital of short distances" is designed in such a way that patients are optimally guided and, for example, life-saving areas such as shock rooms are only a few meters away from the arrival hall for ambulances. One highlight of the new clinic is its high-tech diagnostics and operations, which use the latest technology, digitalization and artificial intelligence to ensure the highest medical quality. But the significance of the new building goes beyond technological and organizational innovations. With modern workplaces, we are creating an attractive environment for medical, nursing and administrative professionals. This new building is a living example of how we ensure access to high-quality medical care and put our "Committed to Life" promise into practice. #FutureFresenius #CommittedToLife

NOW AVAILABLE: Our results for Q3/24. ? Based on the first nine months of this year, we upgraded our Group outlook for fiscal 2024. Organic revenue growth is now expected to grow between 6% to 8% and EBIT growth in constant currency to be in the 8% to 11% range. ?? ? Here are some of the key takeaways: ? ?Group organic revenue growth of 9% to €5.3 billion driven by a strong Kabi performance and good organic growth at Helios.? ?? Strong bottom-line traction: Group EBIT increase in constant currency of 9% to €552 million; EPS growth of 7%. ?? Group-wide cost and productivity savings ahead of plan with target for FY/24 already achieved YTD. ? ?Excellent operating cash flow resulting from focused cash management. ?? Progress on deleveraging: leverage ratio further improved to 3.24x driven by excellent cash flow; leverage target corridor under review. ? ?Fresenius Kabi delivering above the top-end of the structural growth band with organic revenue growth of 11%; strong EBIT margin at 15.9%. ?? Continued strong performance of Growth Vectors at Kabi, led by dynamic growth at Biopharma; Tyenne is in line with expectations and building on strong momentum. ???Fresenius Helios with excellent organic revenue growth of 8%; EBIT margin of 7.9% in line with expectations due to anticipated lower seasonal demand in Spain; last quarter of energy relief funding support. ? Dedicated Helios performance program underway to drive further operational excellence and compensate ending energy relief funding in Germany. Find our full press release here: https://lnkd.in/ezYhd3KT #Q3?#FutureFresenius #CommittedToLife ? Disclaimer: The caption is without corresponding footnotes, which can be retrieved from the slides.

Wishing you all a happy Diwali and celebrations filled with light and joy!????Enjoy the warmth of Diwali with loved ones and sparkling lights!?? #HappyDiwali #FestivalOfLights #CommittedToLife

We are honored to be named one of Germany's best training companies! Our commitment to education shows in a score of 94.4 out of 100 points from Handelsblatt, surpassing last year’s performance. Additionally, we received a full 5-star rating from Capital Magazin for both our apprenticeship and dual study programs. A big thank you to our training teams for your excellent work. We are excited for the future of education at Fresenius! #Training #TeamFresenius #CommittedToLife

This week our German Fresenius Ambassador came together for an After Work gathering in Bad Homburg! It was fantastic to connect with so many incredible Frembassadors, enjoying delicious food, drinks, and inspiring conversations. The Frembassador program is an initiative for Fresenius employees worldwide to engage in employer branding activities and help promote Fresenius as an attractive employer, fostering an incredible community along the way. #AfterWork #TeamFresenius #CommittedToLife

United for a good cause! ??? While our commitment to those affected by breast cancer is year-round, this month we are especially focused on raising awareness and standing in solidarity. Our teams from all over the world – including our colleagues from Fresenius Group, Helios Kliniken GmbH, and Quirónsalud – are contributing through a variety of initiatives. Some inspiring examples: ???? Our Italian colleagues from our MedTech hub in Mirandola joined the local Pink Walk with their families, raising awareness and much needed funds. ???? ???? For the teams of Fresenius Kabi Region Europe and Fresenius Kabi France, both located in Paris, it has become a tradition to gear up for the annual Odyssea Run that successfully raised 6.2 million for breast cancer research over the past two decades. This year, our group was especially large and enthusiastic. ???? Our colleagues in Lithuania took part in the annual Pink Run that supports affected women on their way to recovery. ???? Our team in Ecuador created a mural of hands to show that every hand counts in the fight against breast cancer, engaged in awareness talks and shared tips related to cancer care and prevention. ???? The Women’s VOICE Employee Impact Group from Fresenius Kabi USA joined forces with the American Cancer Society in the fight against breast cancer at Making Strides, a community fundraising event that raises vital funds to support breast cancer patients, survivors, and caregivers throughout their journey. Our post features some snapshots from these activities, capturing the spirit and dedication of our incredible teams, embodying our commitment to life. #BreastCancerAwareness #TeamFresenius #CommittedToLife